OSI Pharmaceuticals Inc (OSIP:US)
was acquired by 4503:JP
OSI Pharmaceuticals, Inc. is a pharmaceutical research and development company commercializing its skills in drug discovery, preclinical research, and drug development. The Company's research programs are focused in the areas of cancer therapeutics, cosmeceuticals, diabetes, and G-protein coupled receptor-directed drug discovery. OSI is involved in research alliances with other companies.